Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk
NCT06557057
·
clinicaltrials.gov ↗
RECRUITING
Status
66
Enrollment
OTHER
Sponsor class
Conditions
HER2-Positive Breast Carcinoma
Interventions
OTHER:
Non-Interventional Study
Sponsor
Mayo Clinic